79362721 - LEEZOVI

Information

  • Trademark
  • 79362721
  • Serial Number
    79362721
  • Registration Number
    7215591
  • Filing Date
    July 28, 2022
    2 years ago
  • Registration Date
    November 14, 2023
    a year ago
  • Transaction Date
    March 12, 2024
    9 months ago
  • Status Date
    November 14, 2023
    a year ago
  • Published for Opposition Date
    August 29, 2023
    a year ago
  • Location Date
    November 14, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    LEIPZIG, MARC J
  • Attorney Docket Number
    04774
    Attorney Name
    Michelle J. Levin
    Law Office Assigned Location Code
    M60
  • Owners
Mark Drawing Code
4000
Mark Identification
LEEZOVI
Case File Statements
  • GS0051: Pharmaceutical preparations for use in treating cancer or autoimmune diseases; veterinary preparations for use in treating cancer or autoimmune diseases in household animals and horses; medicinal preparations for cancer or autoimmune diseases; Reagents and media for medical and veterinary diagnostic purposes; diagnostic reagents for medical use and veterinary diagnostic reagents, namely, reagents containing magnetic beads, antibody reagents and reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of material, especially of biological materials; Reagents for medical use and clinical medical reagents, namely, reagents for use with medical instruments, especially separation instruments, analysis instruments, reactor and imaging instruments; reagents for the processing of biological material, especially tissue, bone marrow, cells, blood and its components, all for medical or veterinary purposes; Media for bacteriological cultures; diagnostic reagents and preparations for medical and veterinary purposes; contrast agents for in-vivo imaging, all for medical and veterinary purposes; pharmaceutical preparations for cellular therapy
  • GS0011: Chemical, biological and biochemical products for industrial, scientific, and diagnostic purposes, namely, biological tissue cultures, diagnostic preparations for scientific use; Chemical preparations for use in separation processes for biological materials; reagents for scientific and research use, namely, reagents for cell separation, labeling reagents, and reagents for the preparation of media, all for commercial and scientific purposes and for the use in medical laboratories; chemical reagents, other than for medical or veterinary purposes with magnetic beads; chemical antibody reagents, other than for medical or veterinary purposes; buffer solutions for scientific purposes in analytical chemistry and chemical reagents, for non-medical purposes, for use with laboratory instruments, especially separation instruments, chemical analysis instruments, reactors and imaging instruments; reagents, other than for medical or veterinary purposes, for processing of biological material, especially tissue, bone marrow, cells, blood; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; cell culture media, for in-vivo imaging, all for scientific purposes; chemical reagents for non-medical purposes, namely, for use in biotechnology, in biological treatment processes and in the biotechnology industry
  • GS0441: Medical services, in particular the field of extracorporeal plasma therapy; medical treatment services, namely, medical treatment of cancer or autoimmune diseases
  • GS0421: Medical, pharmaceutical and biotechnological laboratory services; medical laboratory services and laboratory research services relating to pharmaceuticals, in particular in connection with the manufacture of cell therapeutic agents, cell compounds, cellular medicines, and featuring the selection, stimulation, and activation of cells, as well as the manufacture of medical and scientific kits and reagents
Case File Event Statements
  • 3/12/2024 - 9 months ago
    33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 2/21/2024 - 10 months ago
    32 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 2/21/2024 - 10 months ago
    31 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 2/14/2024 - 10 months ago
    30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 11/14/2023 - a year ago
    29 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 11/14/2023 - a year ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/29/2023 - a year ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/29/2023 - a year ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/9/2023 - a year ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/26/2023 - a year ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/26/2023 - a year ago
    23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/26/2023 - a year ago
    22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/26/2023 - a year ago
    21 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/24/2023 - a year ago
    20 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/24/2023 - a year ago
    19 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/24/2023 - a year ago
    18 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/22/2023 - a year ago
    17 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/19/2023 - a year ago
    16 - CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED Type: CREV
  • 6/28/2023 - a year ago
    15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/28/2023 - a year ago
    14 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 6/28/2023 - a year ago
    13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/28/2023 - a year ago
    12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/28/2023 - a year ago
    11 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 6/28/2023 - a year ago
    10 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 6/24/2023 - a year ago
    9 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 6/21/2023 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/21/2023 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/17/2023 - a year ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 5/16/2023 - a year ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/16/2023 - a year ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/21/2023 - a year ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/17/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/16/2023 - a year ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR